<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">NAR Genom Bioinform</journal-id>
    <journal-id journal-id-type="iso-abbrev">NAR Genom Bioinform</journal-id>
    <journal-id journal-id-type="publisher-id">nargab</journal-id>
    <journal-title-group>
      <journal-title>NAR Genomics and Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2631-9268</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">7671370</article-id>
    <article-id pub-id-type="doi">10.1093/nargab/lqaa038</article-id>
    <article-id pub-id-type="publisher-id">lqaa038</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Standard Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>InMeRF: prediction of pathogenicity of missense variants by individual modeling for each amino acid substitution</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Takeda</surname>
          <given-names>Jun-ichi</given-names>
        </name>
        <xref ref-type="aff" rid="AFF1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Nanatsue</surname>
          <given-names>Kentaro</given-names>
        </name>
        <xref ref-type="aff" rid="AFF1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yamagishi</surname>
          <given-names>Ryosuke</given-names>
        </name>
        <xref ref-type="aff" rid="AFF1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ito</surname>
          <given-names>Mikako</given-names>
        </name>
        <xref ref-type="aff" rid="AFF1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Haga</surname>
          <given-names>Nobuhiko</given-names>
        </name>
        <xref ref-type="aff" rid="AFF2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Hirata</surname>
          <given-names>Hiromi</given-names>
        </name>
        <xref ref-type="aff" rid="AFF3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ogi</surname>
          <given-names>Tomoo</given-names>
        </name>
        <xref ref-type="aff" rid="AFF4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-1529-2750</contrib-id>
        <name>
          <surname>Ohno</surname>
          <given-names>Kinji</given-names>
        </name>
        <!--<email>ohnok@med.nagoya-u.ac.jp</email>-->
        <xref ref-type="aff" rid="AFF1">1</xref>
        <xref ref-type="corresp" rid="COR1"/>
      </contrib>
    </contrib-group>
    <aff id="AFF1"><label>1</label><institution>Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine</institution>, 65 Tsurumai, Showa-ku, Nagoya 466-8550, <country country="JP">Japan</country></aff>
    <aff id="AFF2"><label>2</label><institution>Department of Rehabilitation Medicine, The University of Tokyo Hospital</institution>, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, <country country="JP">Japan</country></aff>
    <aff id="AFF3"><label>3</label><institution>Department of Chemistry and Biological Science, College of Science and Engineering, Aoyama Gakuin University</institution>, 5-10-1 Fuchinobe, Chuo-ku, Sagamihara 252-5258, <country country="JP">Japan</country></aff>
    <aff id="AFF4"><label>4</label><institution>Department of Genetics, Research Institute of Environmental Medicine (RIeM), Nagoya University</institution>, Furo, Chikusa-ku, Nagoya 464-8601, <country country="JP">Japan</country></aff>
    <author-notes>
      <corresp id="COR1">To whom correspondence should be addressed. Tel: +81 52 744 2447; Fax: +81 52 744 2449; Email: <email>ohnok@med.nagoya-u.ac.jp</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <month>6</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2020-05-26">
      <day>26</day>
      <month>5</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>26</day>
      <month>5</month>
      <year>2020</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
    <volume>2</volume>
    <issue>2</issue>
    <elocation-id>lqaa038</elocation-id>
    <history>
      <date date-type="received">
        <day>14</day>
        <month>8</month>
        <year>2019</year>
      </date>
      <date date-type="rev-recd">
        <day>03</day>
        <month>3</month>
        <year>2020</year>
      </date>
      <date date-type="accepted">
        <day>13</day>
        <month>5</month>
        <year>2020</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2019. Published by Oxford University Press on behalf of NAR Genomics and Bioinformatics.</copyright-statement>
      <copyright-year>2020</copyright-year>
      <license license-type="cc-by-nc" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact <email>journals.permissions@oup.com</email></license-p>
      </license>
    </permissions>
    <self-uri xlink:href="lqaa038.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>In predicting the pathogenicity of a nonsynonymous single-nucleotide variant (nsSNV), a radical change in amino acid properties is prone to be classified as being pathogenic. However, not all such nsSNVs are associated with human diseases. We generated random forest (RF) models individually for each amino acid substitution to differentiate pathogenic nsSNVs in the Human Gene Mutation Database and common nsSNVs in dbSNP. We named a set of our models ‘Individual Meta RF’ (InMeRF). Ten-fold cross-validation of InMeRF showed that the areas under the curves (AUCs) of receiver operating characteristic (ROC) and precision–recall curves were on average 0.941 and 0.957, respectively. To compare InMeRF with seven other tools, the eight tools were generated using the same training dataset, and were compared using the same three testing datasets. ROC-AUCs of InMeRF were ranked first in the eight tools. We applied InMeRF to 155 pathogenic and 125 common nsSNVs in seven major genes causing congenital myasthenic syndromes, as well as in <italic>VANGL1</italic> causing spina bifida, and found that the sensitivity and specificity of InMeRF were 0.942 and 0.848, respectively. We made the InMeRF web service, and also made genome-wide InMeRF scores available online (<ext-link ext-link-type="uri" xlink:href="https://www.med.nagoya-u.ac.jp/neurogenetics/InMeRF/">https://www.med.nagoya-u.ac.jp/neurogenetics/InMeRF/</ext-link>).</p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Japan Society for the Promotion of Science</institution>
            <institution-id institution-id-type="DOI">10.13039/501100001691</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>18K14684</award-id>
        <award-id>16H04657</award-id>
        <award-id>19H03329</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Ministry of Health, Labour and Welfare, Japan</institution>
            <institution-id institution-id-type="DOI">10.13039/501100003478</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>H24-Shinkei-Kin-Ippan-005</award-id>
        <award-id>H29-Nanchi-Ippan-030</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Japan Agency for Medical Research and Development</institution>
            <institution-id institution-id-type="DOI">10.13039/100009619</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>19ek0109230</award-id>
        <award-id>20gm1010002</award-id>
        <award-id>20ek0109281</award-id>
        <award-id>20bm0804005</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Center of Neurology and Psychiatry</institution>
            <institution-id institution-id-type="DOI">10.13039/501100009438</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>2-5</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Hori Sciences and Arts Foundation</institution>
            <institution-id institution-id-type="DOI">10.13039/501100005694</institution-id>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="11"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC1">
    <title>INTRODUCTION</title>
    <p>Development of the high-throughput sequencing (HTS) technologies has enabled identification of a large number of single-nucleotide variants (SNVs) in human diseases in a reasonable time at a reasonable cost. Nonsynonymous SNVs (nsSNVs) constitute most of the identified pathogenic SNVs, although the numbers of pathogenic intronic splicing SNVs and pathogenic copy number variations are also increasing (<xref rid="B1" ref-type="bibr">1</xref>). The Human Gene Mutation Database (HGMD) (<xref rid="B2" ref-type="bibr">2</xref>) and ClinVar (<xref rid="B3" ref-type="bibr">3</xref>) are major databases of pathogenic SNVs. Along with advancement of the HTS technologies, <italic>in silico</italic> tools to predict pathogenicity of an identified nsSNV have been developed using various machine learning techniques, including (i) support vector machine (SVM) [CADD (<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B5" ref-type="bibr">5</xref>), MetaSVM (<xref rid="B6" ref-type="bibr">6</xref>) and MutPred (<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B8" ref-type="bibr">8</xref>)], (ii) random forest (RF) [DEOGEN2 (<xref rid="B9" ref-type="bibr">9</xref>), MutPred (<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B8" ref-type="bibr">8</xref>), REVEL (<xref rid="B10" ref-type="bibr">10</xref>) and VEST (<xref rid="B11" ref-type="bibr">11</xref>)], (iii) gradient boosting decision tree [M-CAP (<xref rid="B12" ref-type="bibr">12</xref>)], (iv) logistic regression [MetaLR (<xref rid="B6" ref-type="bibr">6</xref>)], (v) hidden Markov model [FATHMM (<xref rid="B13" ref-type="bibr">13</xref>)] and (vi) deep learning [DANN (<xref rid="B14" ref-type="bibr">14</xref>), PrimateAI (<xref rid="B15" ref-type="bibr">15</xref>) and MVP (<xref rid="B16" ref-type="bibr">16</xref>)].</p>
    <p>We previously used SVM modeling to make IntSplice for predicting the splicing effect of SNVs at intronic positions −50 to −3 (<xref rid="B17" ref-type="bibr">17</xref>). In this communication, we made RF models to differentiate pathogenic nsSNVs in HGMD and common nsSNVs in dbSNP. Compared to SVM modeling, RF modeling is suitable for a large dataset, and requires less computer resources and less efforts in tuning hyperparameters (<xref rid="B18" ref-type="bibr">18</xref>,<xref rid="B19" ref-type="bibr">19</xref>). We named a set of our models ‘Individual Meta RF’ (InMeRF). We called it ‘individual’, because we generated an RF model for each of 150 amino acid (AA) substitutions. Among 20 × 19 = 380 possible AA substitutions, nsSNVs are able to cause 150 AA substitutions. Individual modeling alleviated a possible bias that makes radical AA changes being predicted to be pathogenic. We made an InMeRF web service. We also analyzed all possible nsSNVs in the human genome, and made the genome-wide InMeRF scores available online.</p>
  </sec>
  <sec sec-type="materials|methods" id="SEC2">
    <title>MATERIALS AND METHODS</title>
    <sec id="SEC2-1">
      <title>Generation of InMeRF models</title>
      <p>We used the HGMD Pro release 2015.2 (<xref rid="B2" ref-type="bibr">2</xref>) to obtain pathogenic nsSNVs. Among them, we filtered 72 556 pathogenic nsSNVs with both ‘CLASS = DM’, which stands for disease-causing mutation, and ‘MUT = ALT’, which indicates that an alternative nucleotide is a mutation. Even when an nsSNV was reported in multiple patients, the nsSNV was counted as a single nsSNV in the training dataset. We next extracted 166 161 common nsSNVs from dbSNP build 151 (<xref rid="B20" ref-type="bibr">20</xref>) included in dbNSFP v4.0a (<xref rid="B21" ref-type="bibr">21</xref>), for which a minor allelic frequency (MAF) was &gt;0.001 in 1000Gp3_AF, UK10K_AF, ExAC_AF, gnomAD_exomes_AF or gnomAD_genomes_AF. We then filtered 162 918 common nsSNVs by removing nsSNVs either included in HGMD Pro release 2015.2 (<xref rid="B2" ref-type="bibr">2</xref>) or labeled as ‘clinvar_clnsig = Pathogenic or Likely_pathogenic’ in dbNSFP v4.0a.</p>
      <p>Feature values to differentiate pathogenic and common nsSNVs were obtained from 37 tools in dbNSFP v4.0a. In dbNSFP v4.0a, the scores are normalized so that a pathogenic nsSNV gives rise to a rank score of 1 and a normal nsSNV returns a rank score of 0. We calculated percent coverages of the 37 tools for the pathogenic and common nsSNVs (Table <xref rid="tbl1" ref-type="table">1</xref>). The coverages of M-CAP (<xref rid="B12" ref-type="bibr">12</xref>), MutPred (<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B8" ref-type="bibr">8</xref>) and LINSIGHT (<xref rid="B22" ref-type="bibr">22</xref>) for the common nsSNVs were as low as 37.24%, 6.21% and 3.52%, respectively (Table <xref rid="tbl1" ref-type="table">1</xref>). We thus excluded these three tools, and rank scores of the remaining 34 tools in dbNSFP v4.0a were used as feature values [SIFT (<xref rid="B23" ref-type="bibr">23–26</xref>), SIFT4G (<xref rid="B27" ref-type="bibr">27</xref>), Polyphen2_HDIV (<xref rid="B28" ref-type="bibr">28</xref>), Polyphen2_HVAR (<xref rid="B28" ref-type="bibr">28</xref>), LRT (<xref rid="B29" ref-type="bibr">29</xref>), MutationTaster (<xref rid="B30" ref-type="bibr">30</xref>), MutationAssessor (<xref rid="B31" ref-type="bibr">31</xref>), FATHMM (<xref rid="B13" ref-type="bibr">13</xref>), PROVEAN (<xref rid="B32" ref-type="bibr">32</xref>,<xref rid="B33" ref-type="bibr">33</xref>), VEST4 (<xref rid="B11" ref-type="bibr">11</xref>), MetaSVM (<xref rid="B6" ref-type="bibr">6</xref>), MetaLR (<xref rid="B6" ref-type="bibr">6</xref>), REVEL (<xref rid="B10" ref-type="bibr">10</xref>), MVP (<xref rid="B16" ref-type="bibr">16</xref>), MPC (<xref rid="B34" ref-type="bibr">34</xref>), PrimateAI (<xref rid="B15" ref-type="bibr">15</xref>), DEOGEN2 (<xref rid="B9" ref-type="bibr">9</xref>), CADD (<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B5" ref-type="bibr">5</xref>), DANN (<xref rid="B14" ref-type="bibr">14</xref>), fathmm-MKL (<xref rid="B35" ref-type="bibr">35</xref>), fathmm-XF (<xref rid="B36" ref-type="bibr">36</xref>), Eigen (<xref rid="B37" ref-type="bibr">37</xref>), Eigen-PC (<xref rid="B37" ref-type="bibr">37</xref>), GenoCanyon (<xref rid="B38" ref-type="bibr">38</xref>), integrated_fitCons (<xref rid="B39" ref-type="bibr">39–41</xref>), GERP++ (<xref rid="B42" ref-type="bibr">42</xref>), phyloP100way_vertebrate (<xref rid="B43" ref-type="bibr">43</xref>,<xref rid="B44" ref-type="bibr">44</xref>), phyloP30way_mammalian (<xref rid="B43" ref-type="bibr">43</xref>,<xref rid="B44" ref-type="bibr">44</xref>), phyloP17way_primate (<xref rid="B43" ref-type="bibr">43</xref>,<xref rid="B44" ref-type="bibr">44</xref>), phastCons100way_vertebrate (<xref rid="B43" ref-type="bibr">43</xref>,<xref rid="B44" ref-type="bibr">44</xref>), phastCons30way_mammalian (<xref rid="B43" ref-type="bibr">43</xref>,<xref rid="B44" ref-type="bibr">44</xref>), phastCons17way_primate (<xref rid="B43" ref-type="bibr">43</xref>,<xref rid="B44" ref-type="bibr">44</xref>), SiPhy (<xref rid="B45" ref-type="bibr">45</xref>,<xref rid="B46" ref-type="bibr">46</xref>), and bStatistic (<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B5" ref-type="bibr">5</xref>)]. To make RF models, nsSNVs that lacked one or more of 34 rank scores in dbNSFP v4.0a were also excluded.</p>
      <table-wrap id="tbl1" orientation="portrait" position="float">
        <label>Table 1.</label>
        <caption>
          <p>Thirty-seven tools in dbNSFP v4.0a (<xref rid="B21" ref-type="bibr">21</xref>) and their percent coverage for the sum of 72 556 pathogenic nsSNVs and 162 918 common nsSNVs, which were used to generate InMeRF models</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="1" colspan="1">Tool</th>
              <th rowspan="1" colspan="1">Type</th>
              <th rowspan="1" colspan="1">Pathogenic nsSNVs (%)</th>
              <th rowspan="1" colspan="1">Common nsSNVs (%)</th>
              <th rowspan="1" colspan="1">References</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">SIFT</td>
              <td rowspan="1" colspan="1">Prediction</td>
              <td rowspan="1" colspan="1">97.31</td>
              <td rowspan="1" colspan="1">89.62</td>
              <td rowspan="1" colspan="1">(<xref rid="B23" ref-type="bibr">23–26</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">SIFT4G</td>
              <td rowspan="1" colspan="1">Prediction</td>
              <td rowspan="1" colspan="1">98.12</td>
              <td rowspan="1" colspan="1">93.46</td>
              <td rowspan="1" colspan="1">(<xref rid="B27" ref-type="bibr">27</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Polyphen2_HDIV</td>
              <td rowspan="1" colspan="1">Prediction</td>
              <td rowspan="1" colspan="1">92.14</td>
              <td rowspan="1" colspan="1">80.88</td>
              <td rowspan="1" colspan="1">(<xref rid="B28" ref-type="bibr">28</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Polyphen2_HVAR</td>
              <td rowspan="1" colspan="1">Prediction</td>
              <td rowspan="1" colspan="1">92.14</td>
              <td rowspan="1" colspan="1">80.88</td>
              <td rowspan="1" colspan="1">(<xref rid="B28" ref-type="bibr">28</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">LRT</td>
              <td rowspan="1" colspan="1">Prediction</td>
              <td rowspan="1" colspan="1">93.93</td>
              <td rowspan="1" colspan="1">72.45</td>
              <td rowspan="1" colspan="1">(<xref rid="B29" ref-type="bibr">29</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">MutationTaster</td>
              <td rowspan="1" colspan="1">Prediction</td>
              <td rowspan="1" colspan="1">99.94</td>
              <td rowspan="1" colspan="1">95.72</td>
              <td rowspan="1" colspan="1">(<xref rid="B30" ref-type="bibr">30</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">MutationAssessor</td>
              <td rowspan="1" colspan="1">Prediction</td>
              <td rowspan="1" colspan="1">89.32</td>
              <td rowspan="1" colspan="1">76.07</td>
              <td rowspan="1" colspan="1">(<xref rid="B31" ref-type="bibr">31</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">FATHMM</td>
              <td rowspan="1" colspan="1">Prediction</td>
              <td rowspan="1" colspan="1">98.27</td>
              <td rowspan="1" colspan="1">87.35</td>
              <td rowspan="1" colspan="1">(<xref rid="B13" ref-type="bibr">13</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">PROVEAN</td>
              <td rowspan="1" colspan="1">Prediction</td>
              <td rowspan="1" colspan="1">98.29</td>
              <td rowspan="1" colspan="1">90.39</td>
              <td rowspan="1" colspan="1">(<xref rid="B32" ref-type="bibr">32</xref>,<xref rid="B33" ref-type="bibr">33</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">VEST4</td>
              <td rowspan="1" colspan="1">Prediction</td>
              <td rowspan="1" colspan="1">99.35</td>
              <td rowspan="1" colspan="1">95.72</td>
              <td rowspan="1" colspan="1">(<xref rid="B11" ref-type="bibr">11</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">MetaSVM</td>
              <td rowspan="1" colspan="1">Prediction</td>
              <td rowspan="1" colspan="1">99.40</td>
              <td rowspan="1" colspan="1">94.08</td>
              <td rowspan="1" colspan="1">(<xref rid="B6" ref-type="bibr">6</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">MetaLR</td>
              <td rowspan="1" colspan="1">Prediction</td>
              <td rowspan="1" colspan="1">99.40</td>
              <td rowspan="1" colspan="1">94.08</td>
              <td rowspan="1" colspan="1">(<xref rid="B6" ref-type="bibr">6</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">M-CAP<sup>a</sup></td>
              <td rowspan="1" colspan="1">Prediction</td>
              <td rowspan="1" colspan="1">97.39</td>
              <td rowspan="1" colspan="1">37.24</td>
              <td rowspan="1" colspan="1">(<xref rid="B12" ref-type="bibr">12</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">REVEL</td>
              <td rowspan="1" colspan="1">Prediction</td>
              <td rowspan="1" colspan="1">99.40</td>
              <td rowspan="1" colspan="1">94.08</td>
              <td rowspan="1" colspan="1">(<xref rid="B10" ref-type="bibr">10</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">MutPred<sup>a</sup></td>
              <td rowspan="1" colspan="1">Prediction</td>
              <td rowspan="1" colspan="1">81.09</td>
              <td rowspan="1" colspan="1">6.21</td>
              <td rowspan="1" colspan="1">(<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B8" ref-type="bibr">8</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">MVP</td>
              <td rowspan="1" colspan="1">Prediction</td>
              <td rowspan="1" colspan="1">99.12</td>
              <td rowspan="1" colspan="1">73.85</td>
              <td rowspan="1" colspan="1">(<xref rid="B16" ref-type="bibr">16</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">MPC</td>
              <td rowspan="1" colspan="1">Prediction</td>
              <td rowspan="1" colspan="1">91.76</td>
              <td rowspan="1" colspan="1">75.79</td>
              <td rowspan="1" colspan="1">(<xref rid="B34" ref-type="bibr">34</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">PrimateAI</td>
              <td rowspan="1" colspan="1">Prediction</td>
              <td rowspan="1" colspan="1">96.72</td>
              <td rowspan="1" colspan="1">85.13</td>
              <td rowspan="1" colspan="1">(<xref rid="B15" ref-type="bibr">15</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">DEOGEN2</td>
              <td rowspan="1" colspan="1">Prediction</td>
              <td rowspan="1" colspan="1">94.52</td>
              <td rowspan="1" colspan="1">86.73</td>
              <td rowspan="1" colspan="1">(<xref rid="B9" ref-type="bibr">9</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">CADD</td>
              <td rowspan="1" colspan="1">Prediction</td>
              <td rowspan="1" colspan="1">100.00</td>
              <td rowspan="1" colspan="1">100.00</td>
              <td rowspan="1" colspan="1">(<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B5" ref-type="bibr">5</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">DANN</td>
              <td rowspan="1" colspan="1">Prediction</td>
              <td rowspan="1" colspan="1">100.00</td>
              <td rowspan="1" colspan="1">100.00</td>
              <td rowspan="1" colspan="1">(<xref rid="B14" ref-type="bibr">14</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">fathmm-MKL</td>
              <td rowspan="1" colspan="1">Prediction</td>
              <td rowspan="1" colspan="1">100.00</td>
              <td rowspan="1" colspan="1">100.00</td>
              <td rowspan="1" colspan="1">(<xref rid="B35" ref-type="bibr">35</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">fathmm-XF</td>
              <td rowspan="1" colspan="1">Prediction</td>
              <td rowspan="1" colspan="1">86.76</td>
              <td rowspan="1" colspan="1">92.20</td>
              <td rowspan="1" colspan="1">(<xref rid="B36" ref-type="bibr">36</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Eigen</td>
              <td rowspan="1" colspan="1">Prediction</td>
              <td rowspan="1" colspan="1">87.62</td>
              <td rowspan="1" colspan="1">92.02</td>
              <td rowspan="1" colspan="1">(<xref rid="B37" ref-type="bibr">37</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Eigen-PC</td>
              <td rowspan="1" colspan="1">Prediction</td>
              <td rowspan="1" colspan="1">87.62</td>
              <td rowspan="1" colspan="1">92.02</td>
              <td rowspan="1" colspan="1">(<xref rid="B37" ref-type="bibr">37</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">GenoCanyon</td>
              <td rowspan="1" colspan="1">Prediction</td>
              <td rowspan="1" colspan="1">100.00</td>
              <td rowspan="1" colspan="1">100.00</td>
              <td rowspan="1" colspan="1">(<xref rid="B38" ref-type="bibr">38</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">integrated_fitCons</td>
              <td rowspan="1" colspan="1">Prediction</td>
              <td rowspan="1" colspan="1">87.68</td>
              <td rowspan="1" colspan="1">97.44</td>
              <td rowspan="1" colspan="1">(<xref rid="B39" ref-type="bibr">39–41</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">LINSIGHT<sup>a</sup></td>
              <td rowspan="1" colspan="1">Prediction</td>
              <td rowspan="1" colspan="1">0.07</td>
              <td rowspan="1" colspan="1">3.52</td>
              <td rowspan="1" colspan="1">(<xref rid="B22" ref-type="bibr">22</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">GERP++</td>
              <td rowspan="1" colspan="1">Conservation</td>
              <td rowspan="1" colspan="1">99.98</td>
              <td rowspan="1" colspan="1">98.51</td>
              <td rowspan="1" colspan="1">(<xref rid="B42" ref-type="bibr">42</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">phyloP100way_vertebrate</td>
              <td rowspan="1" colspan="1">Conservation</td>
              <td rowspan="1" colspan="1">100.00</td>
              <td rowspan="1" colspan="1">99.97</td>
              <td rowspan="1" colspan="1">(<xref rid="B43" ref-type="bibr">43</xref>,<xref rid="B44" ref-type="bibr">44</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">phyloP30way_mammalian</td>
              <td rowspan="1" colspan="1">Conservation</td>
              <td rowspan="1" colspan="1">100.00</td>
              <td rowspan="1" colspan="1">99.94</td>
              <td rowspan="1" colspan="1">(<xref rid="B43" ref-type="bibr">43</xref>,<xref rid="B44" ref-type="bibr">44</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">phyloP17way_primate</td>
              <td rowspan="1" colspan="1">Conservation</td>
              <td rowspan="1" colspan="1">100.00</td>
              <td rowspan="1" colspan="1">99.90</td>
              <td rowspan="1" colspan="1">(<xref rid="B43" ref-type="bibr">43</xref>,<xref rid="B44" ref-type="bibr">44</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">phastCons100way_vertebrate</td>
              <td rowspan="1" colspan="1">Conservation</td>
              <td rowspan="1" colspan="1">100.00</td>
              <td rowspan="1" colspan="1">99.97</td>
              <td rowspan="1" colspan="1">(<xref rid="B43" ref-type="bibr">43</xref>,<xref rid="B44" ref-type="bibr">44</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">phastCons30way_mammalian</td>
              <td rowspan="1" colspan="1">Conservation</td>
              <td rowspan="1" colspan="1">100.00</td>
              <td rowspan="1" colspan="1">99.94</td>
              <td rowspan="1" colspan="1">(<xref rid="B43" ref-type="bibr">43</xref>,<xref rid="B44" ref-type="bibr">44</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">phastCons17way_primate</td>
              <td rowspan="1" colspan="1">Conservation</td>
              <td rowspan="1" colspan="1">100.00</td>
              <td rowspan="1" colspan="1">99.90</td>
              <td rowspan="1" colspan="1">(<xref rid="B43" ref-type="bibr">43</xref>,<xref rid="B44" ref-type="bibr">44</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">SiPhy</td>
              <td rowspan="1" colspan="1">Conservation</td>
              <td rowspan="1" colspan="1">99.88</td>
              <td rowspan="1" colspan="1">97.09</td>
              <td rowspan="1" colspan="1">(<xref rid="B45" ref-type="bibr">45</xref>,<xref rid="B46" ref-type="bibr">46</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">bStatistic</td>
              <td rowspan="1" colspan="1">Conservation</td>
              <td rowspan="1" colspan="1">98.93</td>
              <td rowspan="1" colspan="1">98.02</td>
              <td rowspan="1" colspan="1">(<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B5" ref-type="bibr">5</xref>)</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="T1TFN1">
            <p><sup>a</sup>Excluded from features to make our models and from comparison with InMeRF because of low nsSNV coverages.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>The pathogenic and common nsSNVs were classified into 150 different nonsynonymous AA substitutions, which possibly occur by a single-nucleotide substitution. In order to select nsSNVs with high MAFs, the common nsSNVs were sorted in descending order of MAF of 1000Gp3_AF. When MAF was absent in 1000Gp3_AF, MAFs of TWINSUK_AF, ALSPAC_AF, ExAC_AF, gnomAD_exomes_AF and gnomAD_genomes_AF were used in this order. NsSNVs without any MAF were ranked lower than MAF-bearing nsSNVs. In order to make unbiased RF models, the same numbers of pathogenic and common nsSNVs were used for each AA substitution (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S1A</xref>). We confirmed that modeling with all pathogenic nsSNVs and all common nsSNVs made the RF models less dependable compared to the balanced training datasets (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S1B</xref>). We also confirmed that modeling with the same numbers of pathogenic nsSNVs and ‘rare’ common nsSNVs similarly made less dependable RF models (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S1C</xref>). In this ‘rare’ common modeling, nsSNVs were sorted in ascending order of MAF of 1000Gp3_AF to select nsSNVs with low MAFs.</p>
      <p>The 34 rank scores in dbNSFP v4.0a were used as feature values to make RF models to differentiate pathogenic and common nsSNVs. RF modeling was performed using a machine learning library, scikit-learn (<xref rid="B47" ref-type="bibr">47</xref>), on Python version 3.7. In this modeling, hyperparameters were set to (i) n_estimators (range(10, 110, 10)), (ii) criterion (‘gini’, ‘entropy’) and (iii) max_depth (<italic>i</italic> for <italic>i</italic> in range(1, 6, 1)). These hyperparameters represent that (i) the number of trees in the forest is selected from 10 to 100 by 10 steps, (ii) the function to measure the quality of a split is selected as Gini impurity or information gain and (iii) the maximum depth of the tree is selected from 1 to 5 by one step. Optimal hyperparameters were automatically determined by 10-fold cross-validation grid search. RF models were generated independently for each of 150 different AA substitutions. An overview of InMeRF modeling is shown in <xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S1A</xref>.</p>
    </sec>
    <sec id="SEC2-2">
      <title>Comparison of InMeRF with 25 other prediction tools in dbNSFP v4.0a</title>
      <p>To compare InMeRF with 25 other prediction tools (Table <xref rid="tbl1" ref-type="table">1</xref>), we used three testing datasets of VariBenchSelected, predictSNPSelected and SwissVarSelected (<xref rid="B48" ref-type="bibr">48</xref>) derived from VariBench (<xref rid="B49" ref-type="bibr">49</xref>,<xref rid="B50" ref-type="bibr">50</xref>), predictSNP (<xref rid="B51" ref-type="bibr">51</xref>) and SwissVar (<xref rid="B52" ref-type="bibr">52</xref>), respectively (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S2</xref>). Among the 28 prediction tools in dbNSFP v4.0a, M-CAP, MutPred and LINSIGHT were excluded from the comparisons because of low nsSNV coverages, as stated earlier. Some tools might have used subsets of the three testing datasets to generate the models, and are expected to show better predictive performance than the others.</p>
    </sec>
    <sec id="SEC2-3">
      <title>Comparison of InMeRF with 10 other tools in the lack of overlapping nsSNVs between training and testing datasets</title>
      <p>To compare InMeRF with 10 previously reported tools that were generated by an identical CADD training dataset (<xref rid="B48" ref-type="bibr">48</xref>), we generated InMeRF-CADD using the CADD training dataset (<xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S1B</xref>). When a rank score was missing for a specific nsSNV in the testing datasets, an average of all rank scores for an AA substitution of interest was used as a rank score of the missing tool.</p>
    </sec>
    <sec id="SEC2-4">
      <title>Application of InMeRF to nsSNVs associated with congenital myasthenic syndromes and spina bifida</title>
      <p>We predicted the pathogenicity of 155 pathogenic nsSNVs and 125 common nsSNVs in seven major genes (<italic>DOK7</italic>, <italic>MUSK</italic>, <italic>AGRN</italic>, <italic>LRP4</italic>, <italic>CHRNE</italic>, <italic>COLQ</italic> and <italic>GFPT1</italic>) causing congenital myasthenic syndrome (CMS) (<xref rid="B53" ref-type="bibr">53</xref>,<xref rid="B54" ref-type="bibr">54</xref>), as well as in <italic>VANGL1</italic> causing spina bifida.</p>
    </sec>
  </sec>
  <sec sec-type="results" id="SEC3">
    <title>RESULTS</title>
    <sec id="SEC3-1">
      <title>A reason why we developed InMeRF</title>
      <p>We identified p.R335C in <italic>VANGL1</italic> in a patient with spina bifida. An arginine-to-cysteine (R-to-C) substitution causes a radical change in AA properties based on the BLOSUM62 score (<xref rid="B55" ref-type="bibr">55</xref>). Indeed, more pathogenic nsSNVs have been reported in radical AA substitutions compared to common nsSNVs (Figure <xref ref-type="fig" rid="F1">1</xref>). We thus pursued the pathogenicity of p.R335C, but found that p.R335C had no effect on subcellular localization of Vangl1, interaction of Vangl1 with SCRIB and embryonic development of zebrafish (see the Supplementary Information). This failure prompted us to make a prediction model for each AA substitution. Among 20 × 19 = 380 possible AA substitutions, 150 AA substitutions can occur by an SNV, whereas the other 230 AA substitutions require two or three nucleotide changes.</p>
      <fig id="F1" orientation="portrait" position="float">
        <label>Figure 1.</label>
        <caption>
          <p>The ratio of pathogenic nsSNVs to common nsSNVs of each AA substitution is plotted on each category of the BLOSUM62 score (<xref rid="B55" ref-type="bibr">55</xref>). The BLOSUM62 score of -3 like p.R335C in <italic>VANGL1</italic> indicates a radical AA substitution, whereas the score of 3 indicates a slightly deleterious AA substitution. The ratios and BLOSUM62 scores of 150 AA substitutions are indicated in <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S1B</xref>. <italic>P</italic> = 0.001 by the Jonckheere–Terpstra trend test, which is for testing ordered differences in medians, on R version 3.5.</p>
        </caption>
        <graphic xlink:href="lqaa038fig1"/>
      </fig>
    </sec>
    <sec id="SEC3-2">
      <title>Generation of InMeRF models</title>
      <p>To circumvent a possible bias that makes radical AA changes being predicted to be pathogenic, we made an RF model to discriminate pathogenic and common nsSNVs for each of the 150 AA substitutions. InMeRF is thus comprised of 150 RF models representing all possible AA substitutions caused by an SNV. We used 72 556 pathogenic nsSNVs and 162 918 common nsSNVs in dbNSFP v4.0a to make our training dataset. To unbiasedly predict pathogenic and common nsSNVs, we used the same numbers of pathogenic and common nsSNVs for each RF modeling. The number of pathogenic or common nsSNVs used to make each RF model was on average 256.8 ranging from 12 to 1494 (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S1A</xref>). Feature values to differentiate pathogenic and common nsSNVs were obtained from rank scores of 34 tools in dbNSFP v4.0a. Each rank score represents a normalized score of a previously reported prediction tool with a rank score of 1 being pathogenic and a rank score of 0 being normal. In our RF models, pathogenic nsSNVs were predicted to be 1, and normal nsSNVs were predicted to be 0. A threshold to differentiate pathogenic and normal nsSNVs was set to 0.5.</p>
    </sec>
    <sec id="SEC3-3">
      <title>Ten-fold cross-validation of InMeRF models generated by our training dataset</title>
      <p>We evaluated the performance of our RF models by making receiver operating characteristic (ROC) and precision–recall (PR) curves by 10-fold cross-validation. We plotted an area under the curve (AUC) of an ROC curve of each AA substitution against the number of nsSNVs used to make each RF model (Figure <xref ref-type="fig" rid="F2">2A</xref> and <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S1A</xref>). We similarly plotted an AUC of a PR curve of each AA substitution (Figure <xref ref-type="fig" rid="F2">2B</xref> and <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S1A</xref>). We observed that ROC-AUCs and PR-AUCs were mostly independent of the number of nsSNVs in the training dataset, and even &lt;500 nsSNVs mostly gave rise to ROC-AUCs and PR-AUCs of &gt;0.9.</p>
      <fig id="F2" orientation="portrait" position="float">
        <label>Figure 2.</label>
        <caption>
          <p>Scatter plots of the AUC of an ROC curve (<bold>A</bold>) and a PR curve (<bold>B</bold>) against the number of nsSNVs in the training dataset. Values of 150 RF models are individually plotted.</p>
        </caption>
        <graphic xlink:href="lqaa038fig2"/>
      </fig>
      <p>We next calculated seven statistical measures [accuracy, precision/positive prediction value (PPV), recall/sensitivity, specificity, F1 score, negative predictive value (NPV) and Matthews correlation coefficient (MCC)] according to the Human Mutation guidelines (<xref rid="B48" ref-type="bibr">48</xref>,<xref rid="B56" ref-type="bibr">56–57</xref>) using 10-fold cross-validation. Statistical measures of 150 RF models are indicated in <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S1A</xref>, and their means and standard deviations (SDs) are indicated in Table <xref rid="tbl2" ref-type="table">2</xref>. Among the seven statistical measures, MCC had the lowest mean statistical measure of 0.882, whereas specificity had the highest mean statistical measure of 0.949 (Table <xref rid="tbl2" ref-type="table">2</xref>).</p>
      <table-wrap id="tbl2" orientation="portrait" position="float">
        <label>Table 2.</label>
        <caption>
          <p>Seven parameters of InMeRF comprised of 150 RF models by 10-fold cross-validation to evaluate prediction performance indicated in the Human Mutation guidelines (<xref rid="B48" ref-type="bibr">48</xref>,<xref rid="B56" ref-type="bibr">56–57</xref>)</p>
        </caption>
        <table frame="hsides" rules="groups">
          <tbody>
            <tr>
              <td align="center" rowspan="1" colspan="1">
                <inline-graphic xlink:href="lqaa038tbl2.jpg" mimetype="image"/>
              </td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec id="SEC3-5">
      <title>Comparison of InMeRF models with 25 other prediction tools in dbNSFP v4.0a</title>
      <p>We compared InMeRF with 25 prediction tools including 4 recently reported tools (MVP, MPC, PrimateAI and DEOGEN2), which were newly added in dbNSFP v4.0a, using three testing datasets (VariBenchSelected, predictSNPSelected and SwissVarSelected) (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S2</xref>) (<xref rid="B48" ref-type="bibr">48</xref>). Compared to the four recently reported prediction tools, ROC-AUCs of InMeRF were ranked first in all three testing datasets (Figure <xref ref-type="fig" rid="F3">3</xref>). Similarly, compared to the 25 prediction tools, ROC-AUCs of InMeRF were ranked fourth in VariBenchSelected and first in predictSNPSelected and SwissVarSelected (<xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S2</xref> and <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S3</xref>). On average, both ROC-AUC and PR-AUC of InMeRF were ranked first compared to the 25 prediction tools (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S3D</xref>). This analysis, however, can be possibly affected by type 1 circularity, which represents that the same nsSNVs are included in both training and testing datasets (<xref rid="B48" ref-type="bibr">48</xref>). Scores given by InMeRF and by the 25 prediction tools for each nsSNV in the three testing datasets are indicated in <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S4</xref>.</p>
      <fig id="F3" orientation="portrait" position="float">
        <label>Figure 3.</label>
        <caption>
          <p>ROC and PR curves of InMeRF and four newly added prediction tools in dbNSFP v4.0a using testing datasets of VariBenchSelected (<bold>A, B</bold>), predictSNPSelected (<bold>C, D</bold>) and SwissVarSelected (<bold>E, F</bold>). ROC and PR curves of InMeRF and 25 other tools including the 4 tools in this figure are indicated in <xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S2</xref>.</p>
        </caption>
        <graphic xlink:href="lqaa038fig3"/>
      </fig>
    </sec>
    <sec id="SEC3-6">
      <title>Comparison of InMeRF models generated by the CADD training dataset with seven other tools generated by the CADD training dataset</title>
      <p>Grimm <italic>et al.</italic> (<xref rid="B48" ref-type="bibr">48</xref>) generated 10 tools using an identical training dataset derived from CADD (<xref rid="B4" ref-type="bibr">4</xref>). They also made three independent testing datasets (VariBenchSelected, predictSNPSelected and SwissVarSelected) that had no shared nsSNVs with each other or with the CADD training dataset (complete lack of type 1 circularity). One of the 10 tools, MutationTaster (<xref rid="B30" ref-type="bibr">30</xref>), however, had the type 1 circularity stated earlier. Another tool, FATHMM’s weighted (FATHMM-W) (<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B48" ref-type="bibr">48</xref>), had type 2 circularity, which represents that the model is tuned to differentiate genes carrying only common nsSNVs and genes carrying only pathogenic nsSNVs, but not to differentiate nsSNVs within a single gene (<xref rid="B48" ref-type="bibr">48</xref>). Excluding these two tools, we compared InMeRF with the eight remaining tools. To this end, we generated InMeRF-CADD using the CADD training dataset (<xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S1B</xref>). Scores and labels given by InMeRF-CADD and by the eight tools for each nsSNV in the three testing datasets are indicated in <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S5</xref>. Statistical measures of InMeRF-CADD and the eight tools are shown in <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S6</xref>. The mean ROC-AUCs were ranked in the order of InMeRF-CADD, PolyPhen2, MutationAssessor, SIFT, CADD, FATHMM-U, LRT, PhyloP and GERP++. The ROC and PR curves of the four top-ranked tools (InMeRF-CADD, PolyPhen2, MutationAssessor and SIFT) are shown in Figure <xref ref-type="fig" rid="F4">4</xref>. Similarly, the ROC and PR curves of InMeRF-CADD and the eight tools are shown in <xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S3</xref>. Although the ROC-AUC of InMeRF-CADD was ranked first for each of the three datasets, PR-AUC of InMeRF-CADD was ranked second, third and first for VariBenchSelected, predictSNPSelected and SwissVarSelected, respectively (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S7</xref>).</p>
      <fig id="F4" orientation="portrait" position="float">
        <label>Figure 4.</label>
        <caption>
          <p>ROC and PR curves of InMeRF-CADD and three top-ranked tools using testing datasets of VariBenchSelected (<bold>A, B</bold>), predictSNPSelected (<bold>C, D</bold>) and SwissVarSelected (<bold>E, F</bold>). InMeRF-CADD and the three tools (<xref rid="B48" ref-type="bibr">48</xref>) were generated by an identical CADD training dataset. ROC and PR curves of InMeRF-CADD and eight other tools including the three tools in this figure are indicated in <xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S3</xref>.</p>
        </caption>
        <graphic xlink:href="lqaa038fig4"/>
      </fig>
    </sec>
    <sec id="SEC3-7">
      <title>Application of InMeRF to congenital myasthenic syndromes and spina bifida</title>
      <p><italic>DOK7</italic>, <italic>MUSK</italic>, <italic>AGRN</italic>, <italic>LRP4</italic>, <italic>CHRNE</italic>, <italic>COLQ</italic> and <italic>GFPT1</italic> are frequently mutated genes in CMS (<xref rid="B53" ref-type="bibr">53</xref>,<xref rid="B54" ref-type="bibr">54</xref>). In addition, our motivation to develop InMeRF arose from our failure in proving the pathogenicity of p.R335C in <italic>VANGL1</italic> in spina bifida. We thus applied InMeRF to 155 pathogenic nsSNVs and 125 common nsSNVs in these eight genes. InMeRF predicted that 146 out of 155 truly pathogenic nsSNVs are pathogenic (sensitivity = 0.942) and that 106 of 125 truly common nsSNVs are normal (specificity = 0.848) (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S8</xref>). The sensitivity of 0.942 with these eight genes was comparable to the sensitivity (0.930 ± 0.040, mean and SD of 150 RF models) obtained by 10-fold cross-validation of the training dataset (Table <xref rid="tbl2" ref-type="table">2</xref>). In contrast, the specificity of 0.848 was slightly inferior to the specificity (0.949 ± 0.034, mean and SD of 150 RF models) obtained by 10-fold cross-validation (Table <xref rid="tbl2" ref-type="table">2</xref>). Predictions of pathogenic and common nsSNVs in <italic>MUSK</italic> and <italic>VANGL1</italic> are schematically shown in Figure <xref ref-type="fig" rid="F5">5</xref>.</p>
      <fig id="F5" orientation="portrait" position="float">
        <label>Figure 5.</label>
        <caption>
          <p>Examples of application of InMeRF to nsSNVs in <italic>MUSK</italic> (<bold>A</bold>) and <italic>VANGL1</italic> (<bold>B</bold>). Domains and the positions of nsSNVs are drawn to scale. Pathogenic nsSNVs and common nsSNVs with MAF &gt;0.001 are indicated in red and blue letters, respectively. The number of nsSNVs in each category is indicated in parentheses. Pathogenic and common nsSNVs that were correctly predicted by InMeRF are indicated by open circles, whereas erroneously predicted SNVs are indicated by closed circles. (<bold>A</bold>) Ig, immunoglobulin domains; CRD_FZ, frizzled-like cysteine-rich domain; TMD, transmembrane domain; and Pkinase_Tyr, protein tyrosine kinase. (<bold>B</bold>) TMD, transmembrane domain. Arrow indicates the position of p.R335C (see the Supplementary Information).</p>
        </caption>
        <graphic xlink:href="lqaa038fig5"/>
      </fig>
    </sec>
    <sec id="SEC3-8">
      <title>Web service of InMeRF</title>
      <p>We made a web service for InMeRF at <ext-link ext-link-type="uri" xlink:href="https://www.med.nagoya-u.ac.jp/neurogenetics/InMeRF/">https://www.med.nagoya-u.ac.jp/neurogenetics/InMeRF/</ext-link>. The InMeRF web service accepts (i) a genomic coordinate according to GRCh37/hg19, (ii) a genomic coordinate according to GRCh38/hg38, (iii) HUGO Gene Nomenclature Committee gene symbol or (iv) Ensembl Transcript ID. An nsSNV is predicted to be pathogenic when the probability of pathogenicity is ≥0.5, and the predicted result is returned to the same web page. When a genomic coordinate is entered, prediction scores of all possible nsSNVs for all transcripts annotated in Ensembl Release 94 are returned. Figure <xref ref-type="fig" rid="F6">6</xref> shows the prediction result of chr11:46897102 associated with CMS (<xref rid="B58" ref-type="bibr">58</xref>). We also analyzed all nsSNVs registered in dbNSFP v4.0a according to the Ensembl Release 94 annotations on GRCh37/hg19 and GRCh38/hg38. dbNSFP includes all possible nsSNVs in the human genome by <italic>in silico</italic> saturation mutagenesis, and we followed the strategy of dbNSFP. We made the genome-wide pre-analyzed InMeRF scores available under the download tab of the InMeRF web service.</p>
      <fig id="F6" orientation="portrait" position="float">
        <label>Figure 6.</label>
        <caption>
          <p>A screenshot of InMeRF web service. We previously reported that a heteroallelic C→T substitution in <italic>LRP4</italic> at position 46 897 102 (GRCh37/hg19) on chromosome 11 predicting p.R1277H (red circle) in a patient with CMS compromises binding of LRP4 to MuSK and agrin, and reduces clustering of acetylcholine receptor (<xref rid="B58" ref-type="bibr">58</xref>). When the genomic coordinate ‘chr11:46897102’ is entered in the InMeRF web service, the result shows up on the same window.</p>
        </caption>
        <graphic xlink:href="lqaa038fig6"/>
      </fig>
    </sec>
  </sec>
  <sec sec-type="discussion" id="SEC4">
    <title>DISCUSSION</title>
    <p>Failure to identify pathogenicity of p.R335C in <italic>VANGL1</italic> prompted us to develop InMeRF to predict the pathogenicity of genome-wide nsSNVs. We hypothesized that most of the currently available tools tend to predict that minor AA changes are benign, whereas major AA changes are damaging. We thus made individual RF models for 150 AA substitutions. One possible disadvantage of our approach was that the numbers of nsSNVs used to generate an RF model became low. However, we were able to make RF models with ROC-AUC ≥ 0.845 and PR-AUC ≥ 0.882 even with small numbers of training variants (Figure <xref ref-type="fig" rid="F2">2</xref> and <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S1A</xref>). As is commonly recognized in machine learning, we observed that RF models generated with equal numbers of pathogenic and common nsSNVs made more dependable models (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S1A</xref>) than RF models generated with all pathogenic and common nsSNVs (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S1B</xref>). We suppose that individual RF modeling for 150 AA substitutions enhanced the advantage of balancing pathogenic and common nsSNVs. InMeRF was superior to or at least not inferior to the other tools by comparing InMeRF with 25 other prediction tools in dbNSFP v4.0a (Figure <xref ref-type="fig" rid="F3">3</xref>, <xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S2</xref> and <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S3</xref>) and by comparing InMeRF-CADD with 8 other tools (Figure <xref ref-type="fig" rid="F4">4</xref>, <xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S3</xref> and <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S7</xref>) that were generated by the CADD training dataset.</p>
    <p>Type 1 circularity indicates that the same variants are included in both training and testing datasets (<xref rid="B48" ref-type="bibr">48</xref>). With type 1 circularity, a tool can efficiently predict pathogenicity of nsSNVs in the training dataset, but the efficiency is reduced for novel nsSNVs. Prediction tools of nsSNVs are easily subject to type 1 circularity, which spuriously increase prediction accuracies (<xref rid="B48" ref-type="bibr">48</xref>). Although the comparison of InMeRF with 25 other tools could be affected by type 1 circularity, the comparison of InMeRF-CADD with the 8 CADD-based tools should be free from type 1 circularity.</p>
    <p>Type 2 circularity indicates that a model differentiates genes exclusively with common nsSNVs and genes exclusively with pathogenic nsSNVs, but not both in a single gene (<xref rid="B48" ref-type="bibr">48</xref>). The SwissVarSelected testing dataset contains many genes carrying both pathogenic and common nsSNVs in a single gene (<xref rid="B48" ref-type="bibr">48</xref>). We found that both ROC-AUC and PR-AUC of InMeRF-CADD were ranked first with the SwissVarSelected testing dataset (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S7</xref>). Lack of type 2 circularity in InMeRF is also suggested by representative analysis of pathogenic and common nsSNVs in seven frequently mutated genes (<italic>DOK7</italic>, <italic>MUSK</italic>, <italic>AGRN</italic>, <italic>LRP4</italic>, <italic>CHRNE</italic>, <italic>COLQ</italic> and <italic>GFPT1</italic>) causing CMS, and the <italic>VANGL1</italic> gene causing spina bifida (Figure <xref ref-type="fig" rid="F5">5</xref> and <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S8</xref>).</p>
    <p>In RF modeling of InMeRF, we used rank scores of 34 previously reported tools as feature values (<xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S1</xref>). Analysis of feature importance of each tool for 150 RF models disclosed that REVEL (<xref rid="B10" ref-type="bibr">10</xref>), MetaLR (<xref rid="B6" ref-type="bibr">6</xref>), VEST4 (<xref rid="B11" ref-type="bibr">11</xref>), MVP (<xref rid="B16" ref-type="bibr">16</xref>), DEOGEN2 (<xref rid="B9" ref-type="bibr">9</xref>) and MetaSVM (<xref rid="B6" ref-type="bibr">6</xref>) provided the best six feature values in InMeRF (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S9</xref>). These six tools have been reported in or after year 2016. Comparison of ROC-AUC of InMeRF with those of 25 other tools indeed showed that REVEL (<xref rid="B10" ref-type="bibr">10</xref>), MetaLR (<xref rid="B6" ref-type="bibr">6</xref>), VEST4 (<xref rid="B11" ref-type="bibr">11</xref>), MVP (<xref rid="B16" ref-type="bibr">16</xref>), DEOGEN2 (<xref rid="B9" ref-type="bibr">9</xref>) and MetaSVM (<xref rid="B6" ref-type="bibr">6</xref>) were on average ranked second to seventh after InMeRF (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S3D</xref>). We also reduced the number of feature values one by one in descending order of the feature importance (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S9</xref>), and generated 150 RF models. ROC-AUC remained high even when we eliminated less dependable feature values (<xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S4</xref>). InMeRF is thus largely dependent on the performance of these recently reported tools. Superiority of InMeRF over these recently reported tools may lie in the ensemble of AA substitution-specific RF models.</p>
    <p>Development of InMeRF disclosed that the degree of a change in AA properties is likely to have a substantial effect on the prediction of pathogenicity. Lastly, our first motivation to develop InMeRF was satisfied by finding that p.R335C in <italic>VANGL1</italic> was predicted to be benign with an InMeRF score of 0.342.</p>
  </sec>
  <sec sec-type="data-availability" id="SEC5">
    <title>DATA AVAILABILITY</title>
    <p>The InMeRF web service and the genome-wide InMeRF scores are openly available at <ext-link ext-link-type="uri" xlink:href="https://www.med.nagoya-u.ac.jp/neurogenetics/InMeRF/">https://www.med.nagoya-u.ac.jp/neurogenetics/InMeRF/</ext-link>. The ClinVar, dbNSFP and CADD were obtained from openly available databases at <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/clinvar/">https://www.ncbi.nlm.nih.gov/clinvar/</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://sites.google.com/site/jpopgen/dbNSFP/">https://sites.google.com/site/jpopgen/dbNSFP/</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://cadd.gs.washington.edu/">https://cadd.gs.washington.edu/</ext-link>, respectively. HGMD Pro is a commercial database, and is available upon purchase from QIAGEN.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sup1">
      <label>lqaa038_Supplemental_Files</label>
      <media xlink:href="lqaa038_supplemental_files.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ACK1">
    <title>ACKNOWLEDGEMENTS</title>
    <p><italic>Author contributions</italic>: K.O. conceived the idea. J.-i.T., K.N. and R.Y. designed the methods and performed <italic>in silico</italic> analyses. K.N. performed cellular studies under the supervision of M.I. N.H. provided clinical information on a patient. H.H. performed zebrafish studies. J.-i.T., M.I., H.H. and K.O. wrote the manuscript. T.O. helped to provide variant databases. All authors read and approved the final manuscript.</p>
  </ack>
  <sec id="SEC6">
    <title>SUPPLEMENTARY DATA</title>
    <p><ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/nargab/article-lookup/doi/10.1093/nargab/lqaa038#supplementary-data">Supplementary Data</ext-link> are available at NARGAB Online.</p>
  </sec>
  <sec id="SEC7">
    <title>FUNDING</title>
    <p>Japan Society for the Promotion of Science [18K14684, 16H04657 and 19H03329]; Ministry of Health, Labour, and Welfare, Japan [H24-Shinkei-Kin-Ippan-005 and H29-Nanchi-Ippan-030]; Japan Agency for Medical Research and Development [19ek0109230, 20gm1010002, 20ek0109281 and 20bm0804005]; National Center of Neurology and Psychiatry (2-5); Hori Sciences and Arts Foundation.</p>
    <p><italic>Conflict of interest statement</italic>. None declared.</p>
  </sec>
  <ref-list id="REF1">
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lek</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Karczewski</surname><given-names>K.J.</given-names></name>, <name name-style="western"><surname>Minikel</surname><given-names>E.V.</given-names></name>, <name name-style="western"><surname>Samocha</surname><given-names>K.E.</given-names></name>, <name name-style="western"><surname>Banks</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Fennell</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>O’Donnell-Luria</surname><given-names>A.H.</given-names></name>, <name name-style="western"><surname>Ware</surname><given-names>J.S.</given-names></name>, <name name-style="western"><surname>Hill</surname><given-names>A.J.</given-names></name>, <name name-style="western"><surname>Cummings</surname><given-names>B.B.</given-names></name><etal>et al</etal>.</person-group><article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>. <source>Nature</source>. <year>2016</year>; <volume>536</volume>:<fpage>285</fpage>–<lpage>291</lpage>.<pub-id pub-id-type="pmid">27535533</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stenson</surname><given-names>P.D.</given-names></name>, <name name-style="western"><surname>Mort</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Ball</surname><given-names>E.V.</given-names></name>, <name name-style="western"><surname>Evans</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Hayden</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Heywood</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Hussain</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Phillips</surname><given-names>A.D.</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>D.N.</given-names></name></person-group><article-title>The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies</article-title>. <source>Hum. Genet.</source><year>2017</year>; <volume>136</volume>:<fpage>665</fpage>–<lpage>677</lpage>.<pub-id pub-id-type="pmid">28349240</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Landrum</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>J.M.</given-names></name>, <name name-style="western"><surname>Benson</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>G.R.</given-names></name>, <name name-style="western"><surname>Chao</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Chitipiralla</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Hart</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Hoffman</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Jang</surname><given-names>W.</given-names></name><etal>et al</etal>.</person-group><article-title>ClinVar: improving access to variant interpretations and supporting evidence</article-title>. <source>Nucleic Acids Res.</source><year>2018</year>; <volume>46</volume>:<fpage>D1062</fpage>–<lpage>D1067</lpage>.<pub-id pub-id-type="pmid">29165669</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kircher</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Witten</surname><given-names>D.M.</given-names></name>, <name name-style="western"><surname>Jain</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>O’Roak</surname><given-names>B.J.</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>G.M.</given-names></name>, <name name-style="western"><surname>Shendure</surname><given-names>J.</given-names></name></person-group><article-title>A general framework for estimating the relative pathogenicity of human genetic variants</article-title>. <source>Nat. Genet.</source><year>2014</year>; <volume>46</volume>:<fpage>310</fpage>–<lpage>315</lpage>.<pub-id pub-id-type="pmid">24487276</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rentzsch</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Witten</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>G.M.</given-names></name>, <name name-style="western"><surname>Shendure</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Kircher</surname><given-names>M.</given-names></name></person-group><article-title>CADD: predicting the deleteriousness of variants throughout the human genome</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>; <volume>47</volume>:<fpage>D886</fpage>–<lpage>D894</lpage>.<pub-id pub-id-type="pmid">30371827</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Jian</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Gibbs</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Boerwinkle</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name></person-group><article-title>Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies</article-title>. <source>Hum. Mol. Genet.</source><year>2015</year>; <volume>24</volume>:<fpage>2125</fpage>–<lpage>2137</lpage>.<pub-id pub-id-type="pmid">25552646</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Krishnan</surname><given-names>V.G.</given-names></name>, <name name-style="western"><surname>Mort</surname><given-names>M.E.</given-names></name>, <name name-style="western"><surname>Xin</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Kamati</surname><given-names>K.K.</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>D.N.</given-names></name>, <name name-style="western"><surname>Mooney</surname><given-names>S.D.</given-names></name>, <name name-style="western"><surname>Radivojac</surname><given-names>P.</given-names></name></person-group><article-title>Automated inference of molecular mechanisms of disease from amino acid substitutions</article-title>. <source>Bioinformatics</source>. <year>2009</year>; <volume>25</volume>:<fpage>2744</fpage>–<lpage>2750</lpage>.<pub-id pub-id-type="pmid">19734154</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pejaver</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Mooney</surname><given-names>S.D.</given-names></name>, <name name-style="western"><surname>Radivojac</surname><given-names>P.</given-names></name></person-group><article-title>Missense variant pathogenicity predictors generalize well across a range of function-specific prediction challenges</article-title>. <source>Hum. Mutat.</source><year>2017</year>; <volume>38</volume>:<fpage>1092</fpage>–<lpage>1108</lpage>.<pub-id pub-id-type="pmid">28508593</pub-id></mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raimondi</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Tanyalcin</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Ferte</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Gazzo</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Orlando</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Lenaerts</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Rooman</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Vranken</surname><given-names>W.</given-names></name></person-group><article-title>DEOGEN2: prediction and interactive visualization of single amino acid variant deleteriousness in human proteins</article-title>. <source>Nucleic Acids Res.</source><year>2017</year>; <volume>45</volume>:<fpage>W201</fpage>–<lpage>W206</lpage>.<pub-id pub-id-type="pmid">28498993</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ioannidis</surname><given-names>N.M.</given-names></name>, <name name-style="western"><surname>Rothstein</surname><given-names>J.H.</given-names></name>, <name name-style="western"><surname>Pejaver</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Middha</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>McDonnell</surname><given-names>S.K.</given-names></name>, <name name-style="western"><surname>Baheti</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Musolf</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Holzinger</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Karyadi</surname><given-names>D.</given-names></name><etal>et al</etal>.</person-group><article-title>REVEL: an ensemble method for predicting the pathogenicity of rare missense variants</article-title>. <source>Am. J. Hum. Genet.</source><year>2016</year>; <volume>99</volume>:<fpage>877</fpage>–<lpage>885</lpage>.<pub-id pub-id-type="pmid">27666373</pub-id></mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carter</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Douville</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Stenson</surname><given-names>P.D.</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>D.N.</given-names></name>, <name name-style="western"><surname>Karchin</surname><given-names>R.</given-names></name></person-group><article-title>Identifying Mendelian disease genes with the variant effect scoring tool</article-title>. <source>BMC Genomics</source>. <year>2013</year>; <volume>14</volume>(<issue>Suppl. 3</issue>):<fpage>S3</fpage>.</mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jagadeesh</surname><given-names>K.A.</given-names></name>, <name name-style="western"><surname>Wenger</surname><given-names>A.M.</given-names></name>, <name name-style="western"><surname>Berger</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>Guturu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Stenson</surname><given-names>P.D.</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>D.N.</given-names></name>, <name name-style="western"><surname>Bernstein</surname><given-names>J.A.</given-names></name>, <name name-style="western"><surname>Bejerano</surname><given-names>G.</given-names></name></person-group><article-title>M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity</article-title>. <source>Nat. Genet.</source><year>2016</year>; <volume>48</volume>:<fpage>1581</fpage>–<lpage>1586</lpage>.<pub-id pub-id-type="pmid">27776117</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shihab</surname><given-names>H.A.</given-names></name>, <name name-style="western"><surname>Gough</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>D.N.</given-names></name>, <name name-style="western"><surname>Stenson</surname><given-names>P.D.</given-names></name>, <name name-style="western"><surname>Barker</surname><given-names>G.L.</given-names></name>, <name name-style="western"><surname>Edwards</surname><given-names>K.J.</given-names></name>, <name name-style="western"><surname>Day</surname><given-names>I.N.</given-names></name>, <name name-style="western"><surname>Gaunt</surname><given-names>T.R.</given-names></name></person-group><article-title>Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models</article-title>. <source>Hum. Mutat.</source><year>2013</year>; <volume>34</volume>:<fpage>57</fpage>–<lpage>65</lpage>.<pub-id pub-id-type="pmid">23033316</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quang</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>X.</given-names></name></person-group><article-title>DANN: a deep learning approach for annotating the pathogenicity of genetic variants</article-title>. <source>Bioinformatics</source>. <year>2015</year>; <volume>31</volume>:<fpage>761</fpage>–<lpage>763</lpage>.<pub-id pub-id-type="pmid">25338716</pub-id></mixed-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sundaram</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Padigepati</surname><given-names>S.R.</given-names></name>, <name name-style="western"><surname>McRae</surname><given-names>J.F.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Kosmicki</surname><given-names>J.A.</given-names></name>, <name name-style="western"><surname>Fritzilas</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Hakenberg</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Dutta</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Shon</surname><given-names>J.</given-names></name><etal>et al</etal>.</person-group><article-title>Predicting the clinical impact of human mutation with deep neural networks</article-title>. <source>Nat. Genet.</source><year>2018</year>; <volume>50</volume>:<fpage>1161</fpage>–<lpage>1170</lpage>.<pub-id pub-id-type="pmid">30038395</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Qi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Long</surname><given-names>J.J.</given-names></name>, <name name-style="western"><surname>Chung</surname><given-names>W.K.</given-names></name>, <name name-style="western"><surname>Guan</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>Y.</given-names></name></person-group><article-title>MVP: predicting pathogenicity of missense variants by deep neural networks</article-title>. <year>2018</year>; <comment>2 April, 2018, preprint: not peer reviewed</comment><pub-id pub-id-type="doi">10.1101/259390</pub-id>.</mixed-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shibata</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Okuno</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Rahman</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Azuma</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Takeda</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Masuda</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Selcen</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Engel</surname><given-names>A.G.</given-names></name>, <name name-style="western"><surname>Ohno</surname><given-names>K.</given-names></name></person-group><article-title>IntSplice: prediction of the splicing consequences of intronic single-nucleotide variations in the human genome</article-title>. <source>J. Hum. Genet.</source><year>2016</year>; <volume>61</volume>:<fpage>633</fpage>–<lpage>640</lpage>.<pub-id pub-id-type="pmid">27009626</pub-id></mixed-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mao</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Raj Kumar</surname><given-names>P.K.</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>C.</given-names></name></person-group><article-title>Comparative analyses between retained introns and constitutively spliced introns in <italic>Arabidopsis thaliana</italic> using random forest and support vector machine</article-title>. <source>PLoS One</source>. <year>2014</year>; <volume>9</volume>:<fpage>e104049</fpage>.<pub-id pub-id-type="pmid">25110928</pub-id></mixed-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nair</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Dutta</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Manian</surname><given-names>S.S.</given-names></name>, <name name-style="western"><surname>S</surname><given-names>R.K.</given-names></name>, <name name-style="western"><surname>Jayaraman</surname><given-names>V.K.</given-names></name></person-group><article-title>Identification of penicillin-binding proteins employing support vector machines and random forest</article-title>. <source>Bioinformation</source>. <year>2013</year>; <volume>9</volume>:<fpage>481</fpage>–<lpage>484</lpage>.<pub-id pub-id-type="pmid">23847404</pub-id></mixed-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sherry</surname><given-names>S.T.</given-names></name>, <name name-style="western"><surname>Ward</surname><given-names>M.H.</given-names></name>, <name name-style="western"><surname>Kholodov</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Baker</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Phan</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Smigielski</surname><given-names>E.M.</given-names></name>, <name name-style="western"><surname>Sirotkin</surname><given-names>K.</given-names></name></person-group><article-title>dbSNP: the NCBI database of genetic variation</article-title>. <source>Nucleic Acids Res.</source><year>2001</year>; <volume>29</volume>:<fpage>308</fpage>–<lpage>311</lpage>.<pub-id pub-id-type="pmid">11125122</pub-id></mixed-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Boerwinkle</surname><given-names>E.</given-names></name></person-group><article-title>dbNSFP v3.0: a one-stop database of functional predictions and annotations for human nonsynonymous and splice-site SNVs</article-title>. <source>Hum. Mutat.</source><year>2016</year>; <volume>37</volume>:<fpage>235</fpage>–<lpage>241</lpage>.<pub-id pub-id-type="pmid">26555599</pub-id></mixed-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>Y.F.</given-names></name>, <name name-style="western"><surname>Gulko</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Siepel</surname><given-names>A.</given-names></name></person-group><article-title>Fast, scalable prediction of deleterious noncoding variants from functional and population genomic data</article-title>. <source>Nat. Genet.</source><year>2017</year>; <volume>49</volume>:<fpage>618</fpage>–<lpage>624</lpage>.<pub-id pub-id-type="pmid">28288115</pub-id></mixed-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ng</surname><given-names>P.C.</given-names></name>, <name name-style="western"><surname>Henikoff</surname><given-names>S.</given-names></name></person-group><article-title>Predicting deleterious amino acid substitutions</article-title>. <source>Genome Res.</source><year>2001</year>; <volume>11</volume>:<fpage>863</fpage>–<lpage>874</lpage>.<pub-id pub-id-type="pmid">11337480</pub-id></mixed-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ng</surname><given-names>P.C.</given-names></name>, <name name-style="western"><surname>Henikoff</surname><given-names>S.</given-names></name></person-group><article-title>Accounting for human polymorphisms predicted to affect protein function</article-title>. <source>Genome Res.</source><year>2002</year>; <volume>12</volume>:<fpage>436</fpage>–<lpage>446</lpage>.<pub-id pub-id-type="pmid">11875032</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ng</surname><given-names>P.C.</given-names></name>, <name name-style="western"><surname>Henikoff</surname><given-names>S.</given-names></name></person-group><article-title>SIFT: predicting amino acid changes that affect protein function</article-title>. <source>Nucleic Acids Res.</source><year>2003</year>; <volume>31</volume>:<fpage>3812</fpage>–<lpage>3814</lpage>.<pub-id pub-id-type="pmid">12824425</pub-id></mixed-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Henikoff</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>P.C.</given-names></name></person-group><article-title>Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm</article-title>. <source>Nat. Protoc.</source><year>2009</year>; <volume>4</volume>:<fpage>1073</fpage>–<lpage>1081</lpage>.<pub-id pub-id-type="pmid">19561590</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vaser</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Adusumalli</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Leng</surname><given-names>S.N.</given-names></name>, <name name-style="western"><surname>Sikic</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>P.C.</given-names></name></person-group><article-title>SIFT missense predictions for genomes</article-title>. <source>Nat. Protoc.</source><year>2016</year>; <volume>11</volume>:<fpage>1</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">26633127</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adzhubei</surname><given-names>I.A.</given-names></name>, <name name-style="western"><surname>Schmidt</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Peshkin</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Ramensky</surname><given-names>V.E.</given-names></name>, <name name-style="western"><surname>Gerasimova</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Bork</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Kondrashov</surname><given-names>A.S.</given-names></name>, <name name-style="western"><surname>Sunyaev</surname><given-names>S.R.</given-names></name></person-group><article-title>A method and server for predicting damaging missense mutations</article-title>. <source>Nat. Methods</source>. <year>2010</year>; <volume>7</volume>:<fpage>248</fpage>–<lpage>249</lpage>.<pub-id pub-id-type="pmid">20354512</pub-id></mixed-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chun</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Fay</surname><given-names>J.C.</given-names></name></person-group><article-title>Identification of deleterious mutations within three human genomes</article-title>. <source>Genome Res.</source><year>2009</year>; <volume>19</volume>:<fpage>1553</fpage>–<lpage>1561</lpage>.<pub-id pub-id-type="pmid">19602639</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schwarz</surname><given-names>J.M.</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>D.N.</given-names></name>, <name name-style="western"><surname>Schuelke</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Seelow</surname><given-names>D.</given-names></name></person-group><article-title>MutationTaster2: mutation prediction for the deep-sequencing age</article-title>. <source>Nat. Methods</source>. <year>2014</year>; <volume>11</volume>:<fpage>361</fpage>–<lpage>362</lpage>.<pub-id pub-id-type="pmid">24681721</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reva</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Antipin</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Sander</surname><given-names>C.</given-names></name></person-group><article-title>Predicting the functional impact of protein mutations: application to cancer genomics</article-title>. <source>Nucleic Acids Res.</source><year>2011</year>; <volume>39</volume>:<fpage>e118</fpage>.<pub-id pub-id-type="pmid">21727090</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choi</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>A.P.</given-names></name></person-group><article-title>PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels</article-title>. <source>Bioinformatics</source>. <year>2015</year>; <volume>31</volume>:<fpage>2745</fpage>–<lpage>2747</lpage>.<pub-id pub-id-type="pmid">25851949</pub-id></mixed-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choi</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Sims</surname><given-names>G.E.</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>J.R.</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>A.P.</given-names></name></person-group><article-title>Predicting the functional effect of amino acid substitutions and indels</article-title>. <source>PLoS One</source>. <year>2012</year>; <volume>7</volume>:<fpage>e46688</fpage>.<pub-id pub-id-type="pmid">23056405</pub-id></mixed-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Samocha</surname><given-names>K.E.</given-names></name>, <name name-style="western"><surname>Kosmicki</surname><given-names>J.A.</given-names></name>, <name name-style="western"><surname>Karczewski</surname><given-names>K.J.</given-names></name>, <name name-style="western"><surname>O’Donnell-Luria</surname><given-names>A.H.</given-names></name>, <name name-style="western"><surname>Pierce-Hoffman</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>MacArthur</surname><given-names>D.G.</given-names></name>, <name name-style="western"><surname>Neale</surname><given-names>B.M.</given-names></name>, <name name-style="western"><surname>Daly</surname><given-names>M.J.</given-names></name></person-group><article-title>Regional missense constraint improves variant deleteriousness prediction</article-title>. <year>2017</year>; <comment>12 June 2017, preprint: not peer reviewed</comment><pub-id pub-id-type="doi">10.1101/148353</pub-id>.</mixed-citation>
    </ref>
    <ref id="B35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shihab</surname><given-names>H.A.</given-names></name>, <name name-style="western"><surname>Rogers</surname><given-names>M.F.</given-names></name>, <name name-style="western"><surname>Gough</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Mort</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>D.N.</given-names></name>, <name name-style="western"><surname>Day</surname><given-names>I.N.</given-names></name>, <name name-style="western"><surname>Gaunt</surname><given-names>T.R.</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>C.</given-names></name></person-group><article-title>An integrative approach to predicting the functional effects of non-coding and coding sequence variation</article-title>. <source>Bioinformatics</source>. <year>2015</year>; <volume>31</volume>:<fpage>1536</fpage>–<lpage>1543</lpage>.<pub-id pub-id-type="pmid">25583119</pub-id></mixed-citation>
    </ref>
    <ref id="B36">
      <label>36.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rogers</surname><given-names>M.F.</given-names></name>, <name name-style="western"><surname>Shihab</surname><given-names>H.A.</given-names></name>, <name name-style="western"><surname>Mort</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>D.N.</given-names></name>, <name name-style="western"><surname>Gaunt</surname><given-names>T.R.</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>C.</given-names></name></person-group><article-title>FATHMM-XF: accurate prediction of pathogenic point mutations via extended features</article-title>. <source>Bioinformatics</source>. <year>2018</year>; <volume>34</volume>:<fpage>511</fpage>–<lpage>513</lpage>.<pub-id pub-id-type="pmid">28968714</pub-id></mixed-citation>
    </ref>
    <ref id="B37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ionita-Laza</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>McCallum</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Buxbaum</surname><given-names>J.D.</given-names></name></person-group><article-title>A spectral approach integrating functional genomic annotations for coding and noncoding variants</article-title>. <source>Nat. Genet.</source><year>2016</year>; <volume>48</volume>:<fpage>214</fpage>–<lpage>220</lpage>.<pub-id pub-id-type="pmid">26727659</pub-id></mixed-citation>
    </ref>
    <ref id="B38">
      <label>38.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Cheung</surname><given-names>K.H.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>H.</given-names></name></person-group><article-title>A statistical framework to predict functional non-coding regions in the human genome through integrated analysis of annotation data</article-title>. <source>Sci. Rep.</source><year>2015</year>; <volume>5</volume>:<fpage>10576</fpage>.<pub-id pub-id-type="pmid">26015273</pub-id></mixed-citation>
    </ref>
    <ref id="B39">
      <label>39.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gulko</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Hubisz</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>Gronau</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Siepel</surname><given-names>A.</given-names></name></person-group><article-title>A method for calculating probabilities of fitness consequences for point mutations across the human genome</article-title>. <source>Nat. Genet.</source><year>2015</year>; <volume>47</volume>:<fpage>276</fpage>–<lpage>283</lpage>.<pub-id pub-id-type="pmid">25599402</pub-id></mixed-citation>
    </ref>
    <ref id="B40">
      <label>40.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gronau</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Arbiza</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Mohammed</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Siepel</surname><given-names>A.</given-names></name></person-group><article-title>Inference of natural selection from interspersed genomic elements based on polymorphism and divergence</article-title>. <source>Mol. Biol. Evol.</source><year>2013</year>; <volume>30</volume>:<fpage>1159</fpage>–<lpage>1171</lpage>.<pub-id pub-id-type="pmid">23386628</pub-id></mixed-citation>
    </ref>
    <ref id="B41">
      <label>41.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arbiza</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Gronau</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Aksoy</surname><given-names>B.A.</given-names></name>, <name name-style="western"><surname>Hubisz</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>Gulko</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Keinan</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Siepel</surname><given-names>A.</given-names></name></person-group><article-title>Genome-wide inference of natural selection on human transcription factor binding sites</article-title>. <source>Nat. Genet.</source><year>2013</year>; <volume>45</volume>:<fpage>723</fpage>–<lpage>729</lpage>.<pub-id pub-id-type="pmid">23749186</pub-id></mixed-citation>
    </ref>
    <ref id="B42">
      <label>42.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davydov</surname><given-names>E.V.</given-names></name>, <name name-style="western"><surname>Goode</surname><given-names>D.L.</given-names></name>, <name name-style="western"><surname>Sirota</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>G.M.</given-names></name>, <name name-style="western"><surname>Sidow</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Batzoglou</surname><given-names>S.</given-names></name></person-group><article-title>Identifying a high fraction of the human genome to be under selective constraint using GERP++</article-title>. <source>PLoS Comput. Biol.</source><year>2010</year>; <volume>6</volume>:<fpage>e1001025</fpage>.<pub-id pub-id-type="pmid">21152010</pub-id></mixed-citation>
    </ref>
    <ref id="B43">
      <label>43.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pollard</surname><given-names>K.S.</given-names></name>, <name name-style="western"><surname>Hubisz</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>Rosenbloom</surname><given-names>K.R.</given-names></name>, <name name-style="western"><surname>Siepel</surname><given-names>A.</given-names></name></person-group><article-title>Detection of nonneutral substitution rates on mammalian phylogenies</article-title>. <source>Genome Res.</source><year>2010</year>; <volume>20</volume>:<fpage>110</fpage>–<lpage>121</lpage>.<pub-id pub-id-type="pmid">19858363</pub-id></mixed-citation>
    </ref>
    <ref id="B44">
      <label>44.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siepel</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Bejerano</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Pedersen</surname><given-names>J.S.</given-names></name>, <name name-style="western"><surname>Hinrichs</surname><given-names>A.S.</given-names></name>, <name name-style="western"><surname>Hou</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Rosenbloom</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Clawson</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Spieth</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Hillier</surname><given-names>L.W.</given-names></name>, <name name-style="western"><surname>Richards</surname><given-names>S.</given-names></name><etal>et al</etal>.</person-group><article-title>Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes</article-title>. <source>Genome Res.</source><year>2005</year>; <volume>15</volume>:<fpage>1034</fpage>–<lpage>1050</lpage>.<pub-id pub-id-type="pmid">16024819</pub-id></mixed-citation>
    </ref>
    <ref id="B45">
      <label>45.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lindblad-Toh</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Garber</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Zuk</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>M.F.</given-names></name>, <name name-style="western"><surname>Parker</surname><given-names>B.J.</given-names></name>, <name name-style="western"><surname>Washietl</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Kheradpour</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Ernst</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Jordan</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Mauceli</surname><given-names>E.</given-names></name><etal>et al</etal>.</person-group><article-title>A high-resolution map of human evolutionary constraint using 29 mammals</article-title>. <source>Nature</source>. <year>2011</year>; <volume>478</volume>:<fpage>476</fpage>–<lpage>482</lpage>.<pub-id pub-id-type="pmid">21993624</pub-id></mixed-citation>
    </ref>
    <ref id="B46">
      <label>46.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garber</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Guttman</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Clamp</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Zody</surname><given-names>M.C.</given-names></name>, <name name-style="western"><surname>Friedman</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>X.</given-names></name></person-group><article-title>Identifying novel constrained elements by exploiting biased substitution patterns</article-title>. <source>Bioinformatics</source>. <year>2009</year>; <volume>25</volume>:<fpage>i54</fpage>–<lpage>i62</lpage>.<pub-id pub-id-type="pmid">19478016</pub-id></mixed-citation>
    </ref>
    <ref id="B47">
      <label>47.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pedregosa</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Varoquaux</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Gramfort</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Michel</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Thirion</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Grisel</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Blondel</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Prettenhofer</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Weiss</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Dubourg</surname><given-names>V.</given-names></name><etal>et al</etal>.</person-group><article-title>scikit-learn: machine learning in Python</article-title>. <source>J. Mach. Learn. Res.</source><year>2011</year>; <volume>12</volume>:<fpage>2825</fpage>–<lpage>2830</lpage>.</mixed-citation>
    </ref>
    <ref id="B48">
      <label>48.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grimm</surname><given-names>D.G.</given-names></name>, <name name-style="western"><surname>Azencott</surname><given-names>C.A.</given-names></name>, <name name-style="western"><surname>Aicheler</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Gieraths</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>MacArthur</surname><given-names>D.G.</given-names></name>, <name name-style="western"><surname>Samocha</surname><given-names>K.E.</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>D.N.</given-names></name>, <name name-style="western"><surname>Stenson</surname><given-names>P.D.</given-names></name>, <name name-style="western"><surname>Daly</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>Smoller</surname><given-names>J.W.</given-names></name><etal>et al</etal>.</person-group><article-title>The evaluation of tools used to predict the impact of missense variants is hindered by two types of circularity</article-title>. <source>Hum. Mutat.</source><year>2015</year>; <volume>36</volume>:<fpage>513</fpage>–<lpage>523</lpage>.<pub-id pub-id-type="pmid">25684150</pub-id></mixed-citation>
    </ref>
    <ref id="B49">
      <label>49.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thusberg</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Olatubosun</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Vihinen</surname><given-names>M.</given-names></name></person-group><article-title>Performance of mutation pathogenicity prediction methods on missense variants</article-title>. <source>Hum. Mutat.</source><year>2011</year>; <volume>32</volume>:<fpage>358</fpage>–<lpage>368</lpage>.<pub-id pub-id-type="pmid">21412949</pub-id></mixed-citation>
    </ref>
    <ref id="B50">
      <label>50.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sasidharan Nair</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Vihinen</surname><given-names>M.</given-names></name></person-group><article-title>VariBench: a benchmark database for variations</article-title>. <source>Hum. Mutat.</source><year>2013</year>; <volume>34</volume>:<fpage>42</fpage>–<lpage>49</lpage>.<pub-id pub-id-type="pmid">22903802</pub-id></mixed-citation>
    </ref>
    <ref id="B51">
      <label>51.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bendl</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Stourac</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Salanda</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Pavelka</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Wieben</surname><given-names>E.D.</given-names></name>, <name name-style="western"><surname>Zendulka</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Brezovsky</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Damborsky</surname><given-names>J.</given-names></name></person-group><article-title>PredictSNP: robust and accurate consensus classifier for prediction of disease-related mutations</article-title>. <source>PLoS Comput. Biol.</source><year>2014</year>; <volume>10</volume>:<fpage>e1003440</fpage>.<pub-id pub-id-type="pmid">24453961</pub-id></mixed-citation>
    </ref>
    <ref id="B52">
      <label>52.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mottaz</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>David</surname><given-names>F.P.</given-names></name>, <name name-style="western"><surname>Veuthey</surname><given-names>A.L.</given-names></name>, <name name-style="western"><surname>Yip</surname><given-names>Y.L.</given-names></name></person-group><article-title>Easy retrieval of single amino-acid polymorphisms and phenotype information using SwissVar</article-title>. <source>Bioinformatics</source>. <year>2010</year>; <volume>26</volume>:<fpage>851</fpage>–<lpage>852</lpage>.<pub-id pub-id-type="pmid">20106818</pub-id></mixed-citation>
    </ref>
    <ref id="B53">
      <label>53.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ohno</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Ohkawara</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Ito</surname><given-names>M.</given-names></name></person-group><article-title>Recent advances in congenital myasthenic syndromes</article-title>. <source>Clin. Exp. Neuroimmunol.</source><year>2016</year>; <volume>7</volume>:<fpage>246</fpage>–<lpage>259</lpage>.</mixed-citation>
    </ref>
    <ref id="B54">
      <label>54.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ohno</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Ohkawara</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Ito</surname><given-names>M.</given-names></name></person-group><article-title>Agrin–LRP4–MuSK signaling as a therapeutic target for myasthenia gravis and other neuromuscular disorders</article-title>. <source>Expert Opin. Ther. Targets</source>. <year>2017</year>; <volume>21</volume>:<fpage>949</fpage>–<lpage>958</lpage>.<pub-id pub-id-type="pmid">28825343</pub-id></mixed-citation>
    </ref>
    <ref id="B55">
      <label>55.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Henikoff</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Henikoff</surname><given-names>J.G.</given-names></name></person-group><article-title>Amino acid substitution matrices from protein blocks</article-title>. <source>Proc. Natl Acad. Sci. U.S.A.</source><year>1992</year>; <volume>89</volume>:<fpage>10915</fpage>–<lpage>10919</lpage>.<pub-id pub-id-type="pmid">1438297</pub-id></mixed-citation>
    </ref>
    <ref id="B56">
      <label>56.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vihinen</surname><given-names>M.</given-names></name></person-group><article-title>Guidelines for reporting and using prediction tools for genetic variation analysis</article-title>. <source>Hum. Mutat.</source><year>2013</year>; <volume>34</volume>:<fpage>275</fpage>–<lpage>282</lpage>.<pub-id pub-id-type="pmid">23169447</pub-id></mixed-citation>
    </ref>
    <ref id="B57">
      <label>57.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vihinen</surname><given-names>M.</given-names></name></person-group><article-title>How to evaluate performance of prediction methods? Measures and their interpretation in variation effect analysis</article-title>. <source>BMC Genomics</source>. <year>2012</year>; <volume>13</volume>(<issue>Suppl. 4</issue>):<fpage>S2</fpage>.</mixed-citation>
    </ref>
    <ref id="B58">
      <label>58.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ohkawara</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Cabrera-Serrano</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Nakata</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Milone</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Asai</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Ito</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Ito</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Masuda</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Ito</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Engel</surname><given-names>A.G.</given-names></name><etal>et al</etal>.</person-group><article-title>LRP4 third beta-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner</article-title>. <source>Hum. Mol. Genet.</source><year>2014</year>; <volume>23</volume>:<fpage>1856</fpage>–<lpage>1868</lpage>.<pub-id pub-id-type="pmid">24234652</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
